Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK) HKSE

19.52

-0.86(-4.22%)

Updated at June 03 01:30PM

Currency In HKD

Valuation

Market Cap6.71B
Enterprise Value6.2B
P/E Ratio22.16
PEG Ratio0.15
Price/Sales Ratio4.94
Price/Book Ratio1.66
Enterprise/Revenue4.45
Enterprise/EBITDA20.28

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin0.23
Operating Margin0.19

Management Effectiveness

Return On Assets0.07
Return On Equity0.08

Income Statement

Revenue1.06B
Revenue/Share3.31
Gross Profit762.92M
EBITDA231.92M
Net Income244.37M
Diluted EPS0.76

Balance Sheet

Total Cash1.73B
Total Cash/Share5.42
Total Debt63.67M
Total Debt/Equity0.02
Current Ratio5.98
Book Value Per Share10.11

Price History

52-Week Change3.18
52-Week High28
52-Week Low18.24
Moving Average 50 Days22.64
Moving Average 200 Days23.61

Statistics

Average Volume705,806
Shares Outstanding310.76M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.31
Trailing Annual Dividend Yield1.85
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A